In this review, we summarize our current knowledge of the roles of sPLA2s in metabolic disorders including obesity, hepatic steatosis, diabetes, insulin resistance, and adipose tissue inflammation. The gene discussed is PLA2G2D; the disease is obesity due to melanocortin 4 receptor deficiency.